# Dogwood Therapeutics, Inc.: filings

DWTX · Nasdaq · CIK 1818844 · [Healthcare](/sectors/healthcare.md) · fiscal year ends Dec 31

Pages: [Overview](/companies/dwtx.md) · [Financials](/companies/dwtx/financials.md) · [Filings](/companies/dwtx/filings.md) · [Insiders](/companies/dwtx/insiders.md)

## Reports and events: 120 filings

Newest first, by EDGAR acceptance time (Eastern). Filter with ?form= one of: `periodic`, `8-K`, `10-K`, `10-Q`, `4`, `proxy`, `13dg`, `all`, or any form this company filed (4 100, 8-K 73, 10-Q 17, SC 13G/A 15, 3 14, CORRESP 11, DEF 14A 9, UPLOAD 9, DEFA14A 7, S-1/A 7, 10-K 6, SC 13G 6, 424B4 5, PRE 14A 5, S-3 5, 424B5 4, ARS 4, EFFECT 4, S-8 4, SCHEDULE 13D/A 4, FWP 3, 4/A 2, SCHEDULE 13G 2, SCHEDULE 13G/A 2, 10-K/A 1, 5 1, 8-A12B 1, 8-K/A 1, CERT 1, DRS 1, DRSLTR 1, S-1 1, S-3/A 1, SC 13D 1).

| Filed | Accepted | Form | What it is | Accession |
| --- | --- | --- | --- | --- |
| 2026-10-27 | 16:05 ET | [SCHEDULE 13D/A](/filings/0001104659-26-119153.md) | Ownership report, active investor, amended | 0001104659-26-119153 |
| 2026-10-21 | 16:15 ET | [SCHEDULE 13D/A](/filings/0001104659-26-117841.md) | Ownership report, active investor, amended | 0001104659-26-117841 |
| 2026-10-19 | 08:45 ET | [8-K](/filings/0001104659-26-116748.md) | 1.01 Entry into a material agreement; 3.02 Unregistered sale of equity; 8.01 Other events; 9.01 Financial statements and exhibits | 0001104659-26-116748 |
| 2026-08-14 | 11:14 ET | [10-Q](/filings/0001104659-26-096719.md) | Quarterly report, period 2026-06-30 | 0001104659-26-096719 |
| 2026-08-13 | 08:50 ET | [8-K](/filings/0001104659-26-095512.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001104659-26-095512 |
| 2026-06-17 | 16:55 ET | [8-K](/filings/0001104659-26-075204.md) | 5.03 Amendment to articles or bylaws; 5.07 Shareholder vote results; 9.01 Financial statements and exhibits | 0001104659-26-075204 |
| 2026-05-15 | 09:20 ET | [10-Q](/filings/0001104659-26-061938.md) | Quarterly report, period 2026-03-31 | 0001104659-26-061938 |
| 2026-05-14 | 08:50 ET | [8-K](/filings/0001104659-26-060747.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001104659-26-060747 |
| 2026-04-27 | 14:30 ET | [DEF 14A](/filings/0001104659-26-049277.md) | Proxy statement, period 2026-06-16 | 0001104659-26-049277 |
| 2026-03-26 | 09:00 ET | [8-K](/filings/0001104659-26-034928.md) | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001104659-26-034928 |
| 2026-03-18 | 16:30 ET | [10-K](/filings/0001104659-26-031061.md) | Annual report, period 2025-12-31 | 0001104659-26-031061 |
| 2026-03-18 | 09:00 ET | [8-K](/filings/0001104659-26-029992.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001104659-26-029992 |
| 2026-03-12 | 16:30 ET | [8-K](/filings/0001104659-26-027090.md) | 5.07 Shareholder vote results; 9.01 Financial statements and exhibits | 0001104659-26-027090 |
| 2026-02-13 | 16:05 ET | [DEF 14A](/filings/0001104659-26-015180.md) | Proxy statement, period 2026-03-11 | 0001104659-26-015180 |
| 2026-01-20 | 08:30 ET | [8-K](/filings/0001104659-26-004838.md) | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001104659-26-004838 |
| 2026-01-13 | 12:38 ET | [8-K](/filings/0001104659-26-003211.md) | 1.01 Entry into a material agreement; 1.02 Termination of a material agreement; 3.02 Unregistered sale of equity; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001104659-26-003211 |
| 2025-11-28 | 14:15 ET | [8-K](/filings/0001104659-25-116865.md) | 1.01 Entry into a material agreement; 9.01 Financial statements and exhibits | 0001104659-25-116865 |
| 2025-11-25 | 17:30 ET | [SCHEDULE 13D/A](/filings/0001104659-25-116057.md) | Ownership report, active investor, amended | 0001104659-25-116057 |
| 2025-11-21 | 13:01 ET | [8-K](/filings/0001104659-25-114919.md) | 5.02 Departure or appointment of officers or directors; 5.07 Shareholder vote results; 9.01 Financial statements and exhibits | 0001104659-25-114919 |
| 2025-11-07 | 08:45 ET | [10-Q](/filings/0001104659-25-108169.md) | Quarterly report, period 2025-09-30 | 0001104659-25-108169 |
| 2025-11-06 | 09:15 ET | [8-K](/filings/0001104659-25-107471.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001104659-25-107471 |
| 2025-10-20 | 16:30 ET | [DEF 14A](/filings/0001104659-25-100850.md) | Proxy statement, period 2025-11-21 | 0001104659-25-100850 |
| 2025-10-09 | 16:15 ET | [8-K](/filings/0001104659-25-098360.md) | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001104659-25-098360 |
| 2025-09-29 | 07:34 ET | [8-K](/filings/0001104659-25-094109.md) | 1.01 Entry into a material agreement; 3.02 Unregistered sale of equity; 3.03 Change to security holders’ rights; 5.03 Amendment to articles or bylaws; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001104659-25-094109 |
| 2025-08-13 | 10:18 ET | [10-Q](/filings/0001558370-25-011319.md) | Quarterly report, period 2025-06-30 | 0001558370-25-011319 |
| 2025-08-13 | 09:15 ET | [8-K](/filings/0001558370-25-011311.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001558370-25-011311 |
| 2025-07-02 | 16:15 ET | [8-K](/filings/0001558370-25-009060.md) | 5.02 Departure or appointment of officers or directors | 0001558370-25-009060 |
| 2025-06-24 | 10:15 ET | [8-K](/filings/0001558370-25-008817.md) | 5.02 Departure or appointment of officers or directors; 5.07 Shareholder vote results; 9.01 Financial statements and exhibits | 0001558370-25-008817 |
| 2025-05-09 | 11:28 ET | [10-Q](/filings/0001558370-25-007109.md) | Quarterly report, period 2025-03-31 | 0001558370-25-007109 |
| 2025-05-08 | 09:20 ET | [8-K](/filings/0001558370-25-006866.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001558370-25-006866 |
| 2025-04-30 | 08:00 ET | [DEF 14A](/filings/0001558370-25-005927.md) | Proxy statement, period 2025-06-18 | 0001558370-25-005927 |
| 2025-04-03 | 09:10 ET | [8-K](/filings/0001558370-25-004362.md) | 8.01 Other events; 9.01 Financial statements and exhibits | 0001558370-25-004362 |
| 2025-03-31 | 16:44 ET | [10-K](/filings/0001558370-25-004167.md) | Annual report, period 2024-12-31 | 0001558370-25-004167 |
| 2025-03-31 | 15:55 ET | [8-K](/filings/0001558370-25-004150.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001558370-25-004150 |
| 2025-03-17 | 21:11 ET | [SCHEDULE 13D/A](/filings/0001104659-25-024579.md) | Ownership report, active investor, amended | 0001104659-25-024579 |
| 2025-03-14 | 11:47 ET | [8-K](/filings/0001558370-25-002978.md) | 1.01 Entry into a material agreement; 8.01 Other events; 9.01 Financial statements and exhibits | 0001558370-25-002978 |
| 2025-03-12 | 09:00 ET | [8-K](/filings/0001558370-25-002750.md) | 1.01 Entry into a material agreement; 3.02 Unregistered sale of equity; 3.03 Change to security holders’ rights; 5.03 Amendment to articles or bylaws; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001558370-25-002750 |
| 2024-12-18 | 09:30 ET | [8-K/A](/filings/0001558370-24-016346.md) | 9.01 Financial statements and exhibits | 0001558370-24-016346 |
| 2024-11-21 | 09:15 ET | [8-K](/filings/0001558370-24-015884.md) | 3.01 Delisting notice | 0001558370-24-015884 |
| 2024-11-08 | 08:15 ET | [10-Q](/filings/0001558370-24-014957.md) | Quarterly report, period 2024-09-30 | 0001558370-24-014957 |
| 2024-11-07 | 07:15 ET | [8-K](/filings/0001558370-24-014749.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001558370-24-014749 |
| 2024-10-30 | 09:25 ET | [8-K](/filings/0001558370-24-013889.md) | 8.01 Other events; 9.01 Financial statements and exhibits | 0001558370-24-013889 |
| 2024-10-15 | 16:19 ET | [SC 13D](/filings/0001104659-24-108596.md) | Ownership report, active investor | 0001104659-24-108596 |
| 2024-10-07 | 08:02 ET | [8-K](/filings/0001558370-24-013167.md) | 1.01 Entry into a material agreement; 2.01 Completion of an acquisition or disposition; 3.02 Unregistered sale of equity; 3.03 Change to security holders’ rights; 5.02 Departure or appointment of officers or directors; 5.03 Amendment to articles or bylaws; 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0001558370-24-013167 |
| 2024-08-09 | 10:15 ET | [10-Q](/filings/0001558370-24-011686.md) | Quarterly report, period 2024-06-30 | 0001558370-24-011686 |
| 2024-08-08 | 09:30 ET | [8-K](/filings/0001558370-24-011486.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001558370-24-011486 |
| 2024-06-20 | 09:15 ET | [8-K](/filings/0001558370-24-009327.md) | 5.07 Shareholder vote results | 0001558370-24-009327 |
| 2024-06-12 | 09:15 ET | [8-K](/filings/0001558370-24-009066.md) | 3.01 Delisting notice | 0001558370-24-009066 |
| 2024-05-20 | 09:28 ET | [8-K](/filings/0001558370-24-008450.md) | 1.01 Entry into a material agreement; 8.01 Other events; 9.01 Financial statements and exhibits | 0001558370-24-008450 |
| 2024-05-10 | 10:30 ET | [10-Q](/filings/0001558370-24-007713.md) | Quarterly report, period 2024-03-31 | 0001558370-24-007713 |

Page 1 of 3. [Older](/companies/dwtx/filings.md?page=2)
Source: SEC EDGAR, the company’s filing index. Last ingested by Listed: Oct 30, 2026, 16:07 ET. No prices; not investment advice.